Shanghai Pharmaceuticals Holding (02607): The 2019 A-share stock option incentive plan has granted a total of 6.9768 million stock options for the third exercise period.

Shanghai Pharmaceuticals Holding (02607) announced that the company's 2019 A-share stock option incentive plan ("this stock option incentive plan") has granted a total of 6.9768 million stock options for the third exercise period, with exercise period from February 14, 2024, to February 13, 2025, with exercise by voluntary exercise. As of February 13, 2025, the incentive recipients have exercised and completed the transfer registration of 4.8289 million shares, accounting for 69.21% of the total number of exercisable stock options in the current period. A total of 0.7557 million stock options have been reserved for the second exercise period, with exercise period from February 8, 2024, to February 7, 2025, with exercise by voluntary exercise. Up to February 7, 2025, the incentive recipients have exercised and completed the transfer registration of 0.2319 million shares, accounting for 30.68% of the total number of exercisable stock options in the current period.